Your browser doesn't support javascript.
loading
In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways.
Feng, Meizhen; Wang, Deping; Grobler, Jay A; Hazuda, Daria J; Miller, Michael D; Lai, Ming-Tain.
Afiliação
  • Feng M; Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania, USA.
  • Wang D; Department of Chemistry Modeling & Informatics, Merck Research Laboratories, West Point, Pennsylvania, USA.
  • Grobler JA; Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania, USA.
  • Hazuda DJ; Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania, USA.
  • Miller MD; Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania, USA.
  • Lai MT; Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania, USA mingtain_lai@merck.com.
Antimicrob Agents Chemother ; 59(1): 590-8, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25385110
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridonas / Triazóis / HIV-1 / Inibidores da Transcriptase Reversa / Farmacorresistência Viral / Mutação Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridonas / Triazóis / HIV-1 / Inibidores da Transcriptase Reversa / Farmacorresistência Viral / Mutação Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article